An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Abstract
:1. Introduction
2. Molecular Mechanisms of Soluble Aβ Oligomers Formation and Toxicity
2.1. Aβ Oligomers and Membrane Receptors
2.2. Aβ Oligomers Interaction with Cellular Membranes
2.3. Intracellular Aβ Oligomers Affecting Neural Transmission and Excitability
3. Calcium Homeostasis and Oligomer-Mediated Synaptotoxicity
4. Impairment of Synaptic Excitability, Transmission, and Plasticity
5. Oligomers and Alteration of Excitatory/Inhibitory (E/I) Neurotransmission
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Glenner, G.G.; Wong, C.W. Alzheimer’s Disease: Initial Report of the Purification and Characterization of a Novel Cerebrovascular Amyloid Protein. Biochem. Biophys. Res. Commun. 1984, 120, 885–890. [Google Scholar] [CrossRef]
- Hardy, J. The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics. Science 2002, 297, 353–356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hardy, J.; Higgins, G. Alzheimer’s Disease: The Amyloid Cascade Hypothesis. Science 1992, 256, 184–185. [Google Scholar] [CrossRef]
- Terry, R.D.; Masliah, E.; Salmon, D.P.; Butters, N.; DeTeresa, R.; Hill, R.; Hansen, L.A.; Katzman, R. Physical Basis of Cognitive Alterations in Alzheimer’s Disease: Synapse Loss Is the Major Correlate of Cognitive Impairment. Ann. Neurol. 1991, 30, 572–580. [Google Scholar] [CrossRef]
- Haass, C.; Selkoe, D.J. Soluble Protein Oligomers in Neurodegeneration: Lessons from the Alzheimer’s Amyloid β-Peptide. Nat. Rev. Mol. Cell Biol. 2007, 8, 101–112. [Google Scholar] [CrossRef]
- Ferreira, S.T.; Vieira, M.N.N.; De Felice, F.G. Soluble Protein Oligomers as Emerging Toxins in Alzheimer’s and Other Amyloid Diseases. TBMB 2007, 59, 332–345. [Google Scholar] [CrossRef] [PubMed]
- Koffie, R.M.; Meyer-Luehmann, M.; Hashimoto, T.; Adams, K.W.; Mielke, M.L.; Garcia-Alloza, M.; Micheva, K.D.; Smith, S.J.; Kim, M.L.; Lee, V.M.; et al. Oligomeric Amyloid Associates with Postsynaptic Densities and Correlates with Excitatory Synapse Loss near Senile Plaques. Proc. Natl. Acad. Sci. USA 2009, 106, 4012–4017. [Google Scholar] [CrossRef] [Green Version]
- Knowles, R.B.; Wyart, C.; Buldyrev, S.V.; Cruz, L.; Urbanc, B.; Hasselmo, M.E.; Stanley, H.E.; Hyman, B.T. Plaque-Induced Neurite Abnormalities: Implications for Disruption of Neural Networks in Alzheimer’s Disease. Proc. Natl. Acad. Sci. USA 1999, 96, 5274–5279. [Google Scholar] [CrossRef] [Green Version]
- Shankar, G.M.; Li, S.; Mehta, T.H.; Garcia-Munoz, A.; Shepardson, N.E.; Smith, I.; Brett, F.M.; Farrell, M.A.; Rowan, M.J.; Lemere, C.A.; et al. Amyloid-Beta Protein Dimers Isolated Directly from Alzheimer’s Brains Impair Synaptic Plasticity and Memory. Nat. Med. 2008, 14, 837–842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lesne, S.; Koh, M.T.; Kotilinek, L.; Kayed, R.; Glabe, C.G.; Yang, A.; Gallagher, M.; Ashe, K.H. A Specific Amyloid-b Protein Assembly in the Brain Impairs Memory. Nature 2006, 440, 6. [Google Scholar] [CrossRef] [PubMed]
- Walsh, D.M.; Klyubin, I.; Fadeeva, J.V.; Cullen, W.K.; Anwyl, R.; Wolfe, M.S.; Rowan, M.J.; Selkoe, D.J. Naturally Secreted Oligomers of Amyloid β Protein Potently Inhibit Hippocampal Long-Term Potentiation in Vivo. Nature 2002, 416, 535–539. [Google Scholar] [CrossRef]
- Wang, H.-W.; Pasternak, J.F.; Kuo, H.; Ristic, H.; Lambert, M.P.; Chromy, B.; Viola, K.L.; Klein, W.L.; Stine, W.B.; Krafft, G.A.; et al. Soluble Oligomers of b Amyloid (1-42) Inhibit Long-Term Potentiation but Not Long-Term Depression in Rat Dentate Gyrus. Brain Res. 2002, 924, 133–140. [Google Scholar] [CrossRef]
- Chin, J. Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer’s Disease. J. Neurosci. 2005, 25, 9694–9703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Palop, J.J.; Jones, B.; Kekonius, L.; Chin, J.; Yu, G.-Q.; Raber, J.; Masliah, E.; Mucke, L. Neuronal Depletion of Calcium-Dependent Proteins in the Dentate Gyrus Is Tightly Linked to Alzheimer’s Disease-Related Cognitive Deficits. Proc. Natl. Acad. Sci. USA 2003, 100, 9572–9577. [Google Scholar] [CrossRef] [Green Version]
- Gilbert, J.; Shu, S.; Yang, X.; Lu, Y.; Zhu, L.-Q.; Man, H.-Y. β-Amyloid Triggers Aberrant over-Scaling of Homeostatic Synaptic Plasticity. Acta Neuropathol. Commun. 2016, 4, 131. [Google Scholar] [CrossRef] [Green Version]
- Palop, J.J.; Mucke, L. Amyloid-β–Induced Neuronal Dysfunction in Alzheimer’s Disease: From Synapses toward Neural Networks. Nat. Neurosci. 2010, 13, 812–818. [Google Scholar] [CrossRef]
- Palop, J.J.; Chin, J.; Roberson, E.D.; Wang, J.; Thwin, M.T.; Bien-Ly, N.; Yoo, J.; Ho, K.O.; Yu, G.-Q.; Kreitzer, A.; et al. Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer’s Disease. Neuron 2007, 55, 697–711. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Palop, J.J.; Mucke, L. Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin? Neuromol. Med. 2010, 12, 48–55. [Google Scholar] [CrossRef] [Green Version]
- Minkeviciene, R.; Rheims, S.; Dobszay, M.B.; Zilberter, M.; Hartikainen, J.; Fülöp, L.; Penke, B.; Zilberter, Y.; Harkany, T.; Pitkänen, A.; et al. Amyloid Beta-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy. J. Neurosci. 2009, 29, 3453–3462. [Google Scholar] [CrossRef]
- Imfeld, P.; Bodmer, M.; Schuerch, M.; Jick, S.S.; Meier, C.R. Seizures in Patients with Alzheimer’s Disease or Vascular Dementia: A Population-Based Nested Case-Control Analysis: Seizures in Alzheimer’s and Vascular Dementia. Epilepsia 2013, 54, 700–707. [Google Scholar] [CrossRef]
- Amatniek, J.C.; Hauser, W.A.; DelCastillo-Castaneda, C.; Jacobs, D.M.; Marder, K.; Bell, K.; Albert, M.; Brandt, J.; Stern, Y. Incidence and Predictors of Seizures in Patients with Alzheimer’s Disease. Epilepsia 2006, 47, 867–872. [Google Scholar] [CrossRef]
- Irizarry, M.C. Incidence of New-Onset Seizures in Mild to Moderate Alzheimer Disease. Arch. Neurol. 2012, 69, 368. [Google Scholar] [CrossRef] [PubMed]
- Palop, J.J.; Mucke, L. Epilepsy and Cognitive Impairments in Alzheimer Disease. Arch. Neurol. 2009, 66, 435–440. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Larner, A.J. Epileptic Seizures in AD Patients. Neuromol. Med. 2010, 7, 71–77. [Google Scholar] [CrossRef] [PubMed]
- Bellomo, G.; Bologna, S.; Gonnelli, L.; Ravera, E.; Fragai, M.; Lelli, M.; Luchinat, C. Aggregation Kinetics of the Aβ1-40 Peptide Monitored by NMR. Chem. Commun. 2018, 54, 7601–7604. [Google Scholar] [CrossRef] [PubMed]
- Nerelius, C.; Sandegren, A.; Sargsyan, H.; Raunak, R.; Leijonmarck, H.; Chatterjee, U.; Fisahn, A.; Imarisio, S.; Lomas, D.A.; Crowther, D.C.; et al. α-Helix Targeting Reduces Amyloid-β Peptide Toxicity. Proc. Natl. Acad. Sci. USA 2009, 106, 9191–9196. [Google Scholar] [CrossRef] [Green Version]
- Shea, D.; Hsu, C.-C.; Bi, T.M.; Paranjapye, N.; Childers, M.C.; Cochran, J.; Tomberlin, C.P.; Wang, L.; Paris, D.; Zonderman, J.; et al. α-Sheet Secondary Structure in Amyloid β-Peptide Drives Aggregation and Toxicity in Alzheimer’s Disease. Proc. Natl. Acad. Sci. USA 2019, 116, 8895–8900. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boopathi, S.; Kolandaivel, P. Study on the Inter- and Intra-Peptide Salt-Bridge Mechanism of Aβ23–28 Oligomer Interaction with Small Molecules: QM/MM Method. Mol. Biosyst. 2015, 11, 2031–2041. [Google Scholar] [CrossRef]
- Economou, N.J.; Giammona, M.J.; Do, T.D.; Zheng, X.; Teplow, D.B.; Buratto, S.K.; Bowers, M.T. Amyloid β-Protein Assembly and Alzheimer’s Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation. J. Am. Chem. Soc. 2016, 138, 1772–1775. [Google Scholar] [CrossRef] [Green Version]
- Caughey, B.; Lansbury, P.T. Protofibrils, pores, fibrils, and neurodegeneration: Separating the Responsible Protein Aggregates from The Innocent Bystanders. Ann. Rev. Neurosci. 2003, 37, 267–298. [Google Scholar] [CrossRef]
- Glabe, C.G. Structural Classification of Toxic Amyloid Oligomers. J. Biol. Chem. 2008, 283, 5. [Google Scholar] [CrossRef] [Green Version]
- Roychaudhuri, R.; Yang, M.; Hoshi, M.M.; Teplow, D.B. Amyloid β-Protein Assembly and Alzheimer Disease. J. Biol. Chem. 2009, 284, 4749–4753. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, T.H.; Yang, D.S.; Plaskos, N.P.; Go, S.; Yip, C.M.; Fraser, P.E.; Chakrabartty, A. Structural Studies of Soluble Oligomers of the Alzheimer Beta-Amyloid Peptide. J. Mol. Biol. 2000, 297, 73–87. [Google Scholar] [CrossRef] [PubMed]
- Ono, K.; Condron, M.M.; Teplow, D.B. Structure-Neurotoxicity Relationships of Amyloid Beta-Protein Oligomers. Proc. Natl. Acad. Sci. USA 2009, 106, 14745–14750. [Google Scholar] [CrossRef] [Green Version]
- Janson, J.; Ashley, R.H.; Harrison, D.; McIntyre, S.; Butler, P.C. The Mechanism of Islet Amyloid Polypeptide Toxicity Is Membrane Disruption by Intermediate-Sized Toxic Amyloid Particles. Diabetes 1999, 48, 491–498. [Google Scholar] [CrossRef]
- Conway, K.A.; Harper, J.D.; Lansbury, P.T. Fibrils Formed in Vitro from Alpha-Synuclein and Two Mutant Forms Linked to Parkinson’s Disease Are Typical Amyloid. Biochemistry 2000, 39, 2552–2563. [Google Scholar] [CrossRef]
- Lashuel, H.A.; Hartley, D.; Petre, B.M.; Walz, T.; Lansbury, P.T. Neurodegenerative Disease: Amyloid Pores from Pathogenic Mutations. Nature 2002, 418, 291. [Google Scholar] [CrossRef]
- Shafrir, Y.; Durell, S.R.; Anishkin, A.; Guy, H.R. Beta-Barrel Models of Soluble Amyloid Beta Oligomers and Annular Protofibrils. Proteins 2010, 78, 3458–3472. [Google Scholar] [CrossRef] [Green Version]
- Butterfield, S.M.; Lashuel, H.A. Amyloidogenic Protein-Membrane Interactions: Mechanistic Insight from Model Systems. Angew Chem. Int. Ed. Engl. 2010, 49, 5628–5654. [Google Scholar] [CrossRef] [PubMed]
- Gaspar, R.C.; Villarreal, S.A.; Bowles, N.; Hepler, R.W.; Joyce, J.G.; Shughrue, P.J. Oligomers of Beta-Amyloid Are Sequestered into and Seed New Plaques in the Brains of an AD Mouse Model. Exp. Neurol. 2010, 223, 394–400. [Google Scholar] [CrossRef] [PubMed]
- Takahashi, R.H.; Almeida, C.G.; Kearney, P.F.; Yu, F.; Lin, M.T.; Milner, T.A.; Gouras, G.K. Oligomerization of Alzheimer’s Beta-Amyloid within Processes and Synapses of Cultured Neurons and Brain. J. Neurosci. 2004, 24, 3592–3599. [Google Scholar] [CrossRef] [PubMed]
- Kawahara, M.; Kuroda, Y.; Arispe, N.; Rojas, E. Alzheimer’s Beta-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line. J. Biol. Chem. 2000, 275, 14077–14083. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bhatia, R.; Lin, H.; Lal, R. Fresh and Globular Amyloid Beta Protein (1-42) Induces Rapid Cellular Degeneration: Evidence for AbetaP Channel-Mediated Cellular Toxicity. FASEB J. 2000, 14, 1233–1243. [Google Scholar] [CrossRef]
- Arispe, N.; Pollard, H.B.; Rojas, E. Giant Multilevel Cation Channels Formed by Alzheimer Disease Amyloid Beta-Protein [A Beta P-(1-40)] in Bilayer Membranes. Proc. Natl. Acad. Sci. USA 1993, 90, 10573–10577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Arispe, N.; Rojas, E.; Pollard, H.B. Alzheimer Disease Amyloid Beta Protein Forms Calcium Channels in Bilayer Membranes: Blockade by Tromethamine and Aluminum. Proc. Natl. Acad. Sci. USA 1993, 90, 567–571. [Google Scholar] [CrossRef] [Green Version]
- Parodi, J.; Sepúlveda, F.J.; Roa, J.; Opazo, C.; Inestrosa, N.C.; Aguayo, L.G. Beta-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure. J. Biol. Chem. 2010, 285, 2506–2514. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Magdesian, M.H.; Carvalho, M.M.V.F.; Mendes, F.A.; Saraiva, L.M.; Juliano, M.A.; Juliano, L.; Garcia-Abreu, J.; Ferreira, S.T. Amyloid-Beta Binds to the Extracellular Cysteine-Rich Domain of Frizzled and Inhibits Wnt/Beta-Catenin Signaling. J. Biol. Chem. 2008, 283, 9359–9368. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Caspersen, C.; Wang, N.; Yao, J.; Sosunov, A.; Chen, X.; Lustbader, J.W.; Xu, H.W.; Stern, D.; McKhann, G.; Yan, S.D. Mitochondrial Abeta: A Potential Focal Point for Neuronal Metabolic Dysfunction in Alzheimer’s Disease. FASEB J. 2005, 19, 2040–2041. [Google Scholar] [CrossRef] [PubMed]
- Rhee, S.K.; Quist, A.P.; Lal, R. Amyloid β Protein-(1-42) Forms Calcium-Permeable, Zn2+-Sensitive Channel. J. Biol. Chem. 1998, 273, 13379–13382. [Google Scholar] [CrossRef] [Green Version]
- Demuro, A.; Smith, M.; Parker, I. Single-Channel Ca2+ Imaging Implicates Aβ1-42 Amyloid Pores in Alzheimer’s Disease Pathology. J. Cell Biol. 2011, 195, 515–524. [Google Scholar] [CrossRef] [Green Version]
- Demuro, A.; Mina, E.; Kayed, R.; Milton, S.C.; Parker, I.; Glabe, C.G. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers. J. Biol. Chem. 2005, 280, 17294–17300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ramser, E.M.; Gan, K.J.; Decker, H.; Fan, E.Y.; Suzuki, M.M.; Ferreira, S.T.; Silverman, M.A. Amyloid-β Oligomers Induce Tau-Independent Disruption of BDNF Axonal Transport via Calcineurin Activation in Cultured Hippocampal Neurons. MBoC 2013, 24, 2494–2505. [Google Scholar] [CrossRef] [PubMed]
- Bode, D.C.; Baker, M.D.; Viles, J.H. Ion Channel Formation by Amyloid-Β42 Oligomers but Not Amyloid-Β40 in Cellular Membranes. J. Biol. Chem. 2017, 292, 1404–1413. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Calvo-Rodriguez, M.; Hernando-Perez, E.; Nuñez, L.; Villalobos, C. Amyloid β Oligomers Increase ER-Mitochondria Ca2+ Cross Talk in Young Hippocampal Neurons and Exacerbate Aging-Induced Intracellular Ca2+ Remodeling. Front. Cell Neurosci. 2019, 13, 22. [Google Scholar] [CrossRef]
- Zhao, W.-Q.; De Felice, F.G.; Fernandez, S.; Chen, H.; Lambert, M.P.; Quon, M.J.; Krafft, G.A.; Klein, W.L. Amyloid Beta Oligomers Induce Impairment of Neuronal Insulin Receptors. FASEB J. 2008, 22, 246–260. [Google Scholar] [CrossRef] [Green Version]
- Renner, M.; Lacor, P.N.; Velasco, P.T.; Xu, J.; Contractor, A.; Klein, W.L.; Triller, A. Deleterious Effects of Amyloid Beta Oligomers Acting as an Extracellular Scaffold for MGluR5. Neuron 2010, 66, 739–754. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, S.; Hong, S.; Shepardson, N.E.; Walsh, D.M.; Shankar, G.M.; Selkoe, D. Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake. Neuron 2009, 62, 788–801. [Google Scholar] [CrossRef] [Green Version]
- De Felice, F.G.; Velasco, P.T.; Lambert, M.P.; Viola, K.; Fernandez, S.J.; Ferreira, S.T.; Klein, W.L. Abeta Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-Aspartate Receptor-Dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine. J. Biol. Chem. 2007, 282, 11590–11601. [Google Scholar] [CrossRef] [Green Version]
- Chromy, B.A.; Nowak, R.J.; Lambert, M.P.; Viola, K.L.; Chang, L.; Velasco, P.T.; Jones, B.W.; Fernandez, S.J.; Lacor, P.N.; Horowitz, P.; et al. Self-Assembly of Abeta(1-42) into Globular Neurotoxins. Biochemistry 2003, 42, 12749–12760. [Google Scholar] [CrossRef]
- Sun, J.L.; Stokoe, S.A.; Roberts, J.P.; Sathler, M.F.; Nip, K.A.; Shou, J.; Ko, K.; Tsunoda, S.; Kim, S. Co-Activation of Selective Nicotinic Acetylcholine Receptors Is Required to Reverse Beta Amyloid-Induced Ca2+ Hyperexcitation. Neurobiol. Aging 2019, 84, 166–177. [Google Scholar] [CrossRef]
- Snyder, E.M.; Nong, Y.; Almeida, C.G.; Paul, S.; Moran, T.; Choi, E.Y.; Nairn, A.C.; Salter, M.W.; Lombroso, P.J.; Gouras, G.K.; et al. Regulation of NMDA Receptor Trafficking by Amyloid-Beta. Nat. Neurosci. 2005, 8, 1051–1058. [Google Scholar] [CrossRef]
- Costa, C.; Parnetti, L.; Tantucci, M.; Romigi, A.; Siliquini, S.; Cavallucci, V.; Filippo, M.D.; Mazzocchetti, P.; Liguori, C.; Nobili, A.; et al. Epilepsy, Amyloid-b, and D1 Dopamine Receptors: A Possible Pathogenetic Link? Neurobiol. Aging 2016, 11, 161–171. [Google Scholar] [CrossRef]
- Yamamoto, N.; Matsubara, E.; Maeda, S.; Minagawa, H.; Takashima, A.; Maruyama, W.; Michikawa, M.; Yanagisawa, K. A Ganglioside-Induced Toxic Soluble Abeta Assembly. Its Enhanced Formation from Abeta Bearing the Arctic Mutation. J. Biol. Chem. 2007, 282, 2646–2655. [Google Scholar] [CrossRef] [Green Version]
- Yanagisawa, K. Role of Gangliosides in Alzheimer’s Disease. Biochim. Biophys. Acta 2007, 1768, 1943–1951. [Google Scholar] [CrossRef] [Green Version]
- Costantini, C.; Rossi, F.; Formaggio, E.; Bernardoni, R.; Cecconi, D.; Della-Bianca, V. Characterization of the Signaling Pathway Downstream P75 Neurotrophin Receptor Involved in Beta-Amyloid Peptide-Dependent Cell Death. J. Mol. Neurosci. 2005, 25, 141–156. [Google Scholar] [CrossRef]
- Hadi, F.; Akrami, H.; Shahpasand, K.; Fattahi, M.R. Wnt Signalling Pathway and Tau Phosphorylation: A Comprehensive Study on Known Connections. Cell Biochem. Funct. 2020, 38, 686–694. [Google Scholar] [CrossRef] [PubMed]
- Yamin, G. NMDA Receptor-Dependent Signaling Pathways That Underlie Amyloid β-Protein Disruption of LTP in the Hippocampus. J. Neurosci. Res. 2009, 87, 1729–1736. [Google Scholar] [CrossRef] [PubMed]
- Kayed, R.; Lasagna-Reeves, C.A. Molecular Mechanisms of Amyloid Oligomers Toxicity. J. Alzheimer Dis. 2013, 33 (Suppl. 1), S67–S78. [Google Scholar] [CrossRef] [Green Version]
- Serra-Batiste, M.; Ninot-Pedrosa, M.; Bayoumi, M.; Gairí, M.; Maglia, G.; Carulla, N. Aβ42 Assembles into Specific β-Barrel Pore-Forming Oligomers in Membrane-Mimicking Environments. Proc. Natl. Acad. Sci. USA 2016, 113, 10866–10871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Furukawa, K.; Abe, Y.; Akaike, N. Amyloid Beta Protein-Induced Irreversible Current in Rat Cortical Neurones. Neuroreport 1994, 5, 2016–2018. [Google Scholar] [CrossRef] [PubMed]
- Sanderson, K.L.; Butler, L.; Ingram, V.M. Aggregates of a Beta-Amyloid Peptide Are Required to Induce Calcium Currents in Neuron-like Human Teratocarcinoma Cells: Relation to Alzheimer’s Disease. Brain Res. 1997, 744, 7–14. [Google Scholar] [CrossRef]
- Kawahara, M.; Arispe, N.; Kuroda, Y.; Rojas, E. Alzheimer’s Disease Amyloid Beta-Protein Forms Zn(2+)-Sensitive, Cation-Selective Channels across Excised Membrane Patches from Hypothalamic Neurons. Biophys. J. 1997, 73, 67–75. [Google Scholar] [CrossRef] [Green Version]
- Fraser, S.P.; Suh, Y.H.; Djamgoz, M.B. Ionic Effects of the Alzheimer’s Disease Beta-Amyloid Precursor Protein and Its Metabolic Fragments. Trends Neurosci. 1997, 20, 67–72. [Google Scholar] [CrossRef]
- Pike, C.J.; Burdick, D.; Walencewicz, A.J.; Glabe, C.G.; Cotman, C.W. Neurodegeneration Induced by Beta-Amyloid Peptides in Vitro: The Role of Peptide Assembly State. J. Neurosci. 1993, 13, 1676–1687. [Google Scholar] [CrossRef]
- Zhu, Y.J.; Lin, H.; Lal, R. Fresh and Nonfibrillar Amyloid Beta Protein(1-40) Induces Rapid Cellular Degeneration in Aged Human Fibroblasts: Evidence for AbetaP-Channel-Mediated Cellular Toxicity. FASEB J. 2000, 14, 1244–1254. [Google Scholar] [CrossRef]
- Kagan, B.L.; Hirakura, Y.; Azimov, R.; Azimova, R.; Lin, M.-C. The Channel Hypothesis of Alzheimer’s Disease: Current Status. Peptides 2002, 23, 1311–1315. [Google Scholar] [CrossRef]
- Kagan, B.L.; Azimov, R.; Azimova, R. Amyloid Peptide Channels. J. Membr. Biol. 2004, 202, 1–10. [Google Scholar] [CrossRef]
- LaFerla, F.M.; Troncoso, J.C.; Strickland, D.K.; Kawas, C.H.; Jay, G. Neuronal Cell Death in Alzheimer’s Disease Correlates with ApoE Uptake and Intracellular Abeta Stabilization. J. Clin. Investig. 1997, 100, 310–320. [Google Scholar] [CrossRef] [Green Version]
- Wirths, O.; Multhaup, G.; Czech, C.; Blanchard, V.; Moussaoui, S.; Tremp, G.; Pradier, L.; Beyreuther, K.; Bayer, T.A. Intraneuronal Abeta Accumulation Precedes Plaque Formation in Beta-Amyloid Precursor Protein and Presenilin-1 Double-Transgenic Mice. Neurosci. Lett 2001, 306, 116–120. [Google Scholar] [CrossRef]
- D’Andrea, M.R.; Nagele, R.G.; Wang, H.Y.; Peterson, P.A.; Lee, D.H. Evidence That Neurones Accumulating Amyloid Can Undergo Lysis to Form Amyloid Plaques in Alzheimer’s Disease. Histopathology 2001, 38, 120–134. [Google Scholar] [CrossRef] [PubMed]
- Gouras, G.K.; Tsai, J.; Naslund, J.; Vincent, B.; Edgar, M.; Checler, F.; Greenfield, J.P.; Haroutunian, V.; Buxbaum, J.D.; Xu, H.; et al. Intraneuronal Abeta42 Accumulation in Human Brain. Am. J. Pathol. 2000, 156, 15–20. [Google Scholar] [CrossRef]
- Langui, D.; Girardot, N.; El Hachimi, K.H.; Allinquant, B.; Blanchard, V.; Pradier, L.; Duyckaerts, C. Subcellular Topography of Neuronal Abeta Peptide in APPxPS1 Transgenic Mice. Am. J. Pathol. 2004, 165, 1465–1477. [Google Scholar] [CrossRef]
- Mucke, L.; Masliah, E.; Yu, G.Q.; Mallory, M.; Rockenstein, E.M.; Tatsuno, G.; Hu, K.; Kholodenko, D.; Johnson-Wood, K.; McConlogue, L. High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. J. Neurosci. 2000, 20, 4050–4058. [Google Scholar] [CrossRef] [Green Version]
- Takahashi, R.H.; Milner, T.A.; Li, F.; Nam, E.E.; Edgar, M.A.; Yamaguchi, H.; Beal, M.F.; Xu, H.; Greengard, P.; Gouras, G.K. Intraneuronal Alzheimer Abeta42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology. Am. J. Pathol. 2002, 161, 1869–1879. [Google Scholar] [CrossRef]
- Oddo, S.; Caccamo, A.; Shepherd, J.D.; Murphy, M.P.; Golde, T.E.; Kayed, R.; Metherate, R.; Mattson, M.P.; Akbari, Y.; LaFerla, F.M. Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles: Intracellular Abeta and Synaptic Dysfunction. Neuron 2003, 39, 409–421. [Google Scholar] [CrossRef] [Green Version]
- Almeida, C.G.; Tampellini, D.; Takahashi, R.H.; Greengard, P.; Lin, M.T.; Snyder, E.M.; Gouras, G.K. Beta-Amyloid Accumulation in APP Mutant Neurons Reduces PSD-95 and GluR1 in Synapses. Neurobiol. Dis. 2005, 20, 187–198. [Google Scholar] [CrossRef] [PubMed]
- Mohamed, A.; Posse de Chaves, E. Aβ Internalization by Neurons and Glia. Int. J. Alzheimer Dis. 2011, 2011, e127984. [Google Scholar] [CrossRef] [Green Version]
- Vadukul, D.M.; Maina, M.; Franklin, H.; Nardecchia, A.; Serpell, L.C.; Marshall, K.E. Internalisation and Toxicity of Amyloid-β 1-42 Are Influenced by Its Conformation and Assembly State Rather than Size. FEBS Lett. 2020, 594, 3490–3503. [Google Scholar] [CrossRef] [PubMed]
- Yan, S.D.; Fu, J.; Soto, C.; Chen, X.; Zhu, H.; Al-Mohanna, F.; Collison, K.; Zhu, A.; Stern, E.; Saido, T.; et al. An Intracellular Protein That Binds Amyloid-Beta Peptide and Mediates Neurotoxicity in Alzheimer’s Disease. Nature 1997, 389, 689–695. [Google Scholar] [CrossRef] [PubMed]
- Kinoshita, A.; Fukumoto, H.; Shah, T.; Whelan, C.M.; Irizarry, M.C.; Hyman, B.T. Demonstration by FRET of BACE Interaction with the Amyloid Precursor Protein at the Cell Surface and in Early Endosomes. J. Cell Sci. 2003, 116, 3339–3346. [Google Scholar] [CrossRef] [Green Version]
- Chui, D.H.; Dobo, E.; Makifuchi, T.; Akiyama, H.; Kawakatsu, S.; Petit, A.; Checler, F.; Araki, W.; Takahashi, K.; Tabira, T. Apoptotic Neurons in Alzheimer’s Disease Frequently Show Intracellular Abeta42 Labeling. J. Alzheimer Dis. 2001, 3, 231–239. [Google Scholar] [CrossRef]
- Manczak, M.; Anekonda, T.S.; Henson, E.; Park, B.S.; Quinn, J.; Reddy, P.H. Mitochondria Are a Direct Site of Ab Accumulation in Alzheimer’s Disease Neurons: Implications for Free Radical Generation and Oxidative Damage in Disease Progression. 13. Hum. Mol. Genet. 2006, 15, 1437–1449. [Google Scholar] [CrossRef]
- Pagani, L.; Eckert, A. Amyloid-Beta Interaction with Mitochondria. Int. J. Alzheimers Dis. 2011, 2011, 925050. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hansson Petersen, C.A.; Alikhani, N.; Behbahani, H.; Wiehager, B.; Pavlov, P.F.; Alafuzoff, I.; Leinonen, V.; Ito, A.; Winblad, B.; Glaser, E.; et al. The Amyloid Beta-Peptide Is Imported into Mitochondria via the TOM Import Machinery and Localized to Mitochondrial Cristae. Proc. Natl. Acad. Sci. USA 2008, 105, 13145–13150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Keil, U.; Hauptmann, S.; Bonert, A.; Scherping, I.; Eckert, A.; Müller, W.E. Mitochondrial Dysfunction Induced by Disease Relevant AbetaPP and Tau Protein Mutations. J. Alzheimer Dis. 2006, 9, 139–146. [Google Scholar] [CrossRef] [PubMed]
- Tönnies, E.; Trushina, E. Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease. JAD 2017, 57, 1105–1121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chinopoulos, C.; Adam-Vizi, V. Calcium, Mitochondria and Oxidative Stress in Neuronal Pathology. Novel Aspects of an Enduring Theme. FEBS J. 2006, 273, 433–450. [Google Scholar] [CrossRef]
- Chen, J.X.; Yan, S.S. Role of Mitochondrial Amyloid-Beta in Alzheimer’s Disease. J. Alzheimer Dis. 2010, 20 (Suppl. 2), S569–S578. [Google Scholar] [CrossRef] [Green Version]
- Mossmann, D.; Vögtle, F.-N.; Taskin, A.A.; Teixeira, P.F.; Ring, J.; Burkhart, J.M.; Burger, N.; Pinho, C.M.; Tadic, J.; Loreth, D.; et al. Amyloid-β Peptide Induces Mitochondrial Dysfunction by Inhibition of Preprotein Maturation. Cell Metab. 2014, 20, 662–669. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pimplikar, S.W.; Nixon, R.A.; Robakis, N.K.; Shen, J.; Tsai, L.-H. Amyloid-Independent Mechanisms in Alzheimer’s Disease Pathogenesis. J. Neurosci. 2010, 30, 14946–14954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Swerdlow, R.H.; Burns, J.M.; Khan, S.M. The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: Progress and Perspectives. Biochim. Biophys. Acta 2014, 1842, 1219–1231. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Trushina, E.; Nemutlu, E.; Zhang, S.; Christensen, T.; Camp, J.; Mesa, J.; Siddiqui, A.; Tamura, Y.; Sesaki, H.; Wengenack, T.M.; et al. Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer’s Disease. PLoS ONE 2012, 7, e32737. [Google Scholar] [CrossRef] [Green Version]
- Zhang, L.; Trushin, S.; Christensen, T.A.; Tripathi, U.; Hong, C.; Geroux, R.E.; Howell, K.G.; Poduslo, J.F.; Trushina, E. Differential Effect of Amyloid Beta Peptides on Mitochondrial Axonal Trafficking Depends on Their State of Aggregation and Binding to the Plasma Membrane. Neurobiol. Dis. 2018, 114, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Saxton, W.M.; Hollenbeck, P.J. The Axonal Transport of Mitochondria. J. Cell Sci. 2012, 125, 2095–2104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, C.L.; Ho, P.L.; Kintner, D.B.; Sun, D.; Chiu, S.Y. Activity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves. J. Neurosci. 2010, 30, 3555–3566. [Google Scholar] [CrossRef] [PubMed]
- Sheng, Z.-H.; Cai, Q. Mitochondrial Transport in Neurons: Impact on Synaptic Homeostasis and Neurodegeneration. Nat. Rev. Neurosci. 2012, 13, 77–93. [Google Scholar] [CrossRef] [Green Version]
- Attwell, D.; Laughlin, S.B. An Energy Budget for Signaling in the Grey Matter of the Brain. J. Cereb. Blood Flow Metab. 2001, 21, 1133–1145. [Google Scholar] [CrossRef]
- Harris, J.J.; Jolivet, R.; Attwell, D. Synaptic Energy Use and Supply. Neuron 2012, 75, 762–777. [Google Scholar] [CrossRef] [Green Version]
- Sheng, Z.-H. The Interplay of Axonal Energy Homeostasis and Mitochondrial Trafficking and Anchoring. Trends Cell Biol. 2017, 27, 403–416. [Google Scholar] [CrossRef] [PubMed]
- Medler, K.; Gleason, E.L. Mitochondrial Ca(2+) Buffering Regulates Synaptic Transmission between Retinal Amacrine Cells. J. Neurophysiol. 2002, 87, 1426–1439. [Google Scholar] [CrossRef] [Green Version]
- Billups, B.; Forsythe, I.D. Presynaptic Mitochondrial Calcium Sequestration Influences Transmission at Mammalian Central Synapses. J. Neurosci. 2002, 22, 5840–5847. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- David, G.; Barrett, E.F. Mitochondrial Ca2+ Uptake Prevents Desynchronization of Quantal Release and Minimizes Depletion during Repetitive Stimulation of Mouse Motor Nerve Terminals. J. Physiol. 2003, 548, 425–438. [Google Scholar] [CrossRef]
- Tang, Y.; Zucker, R.S. Mitochondrial Involvement in Post-Tetanic Potentiation of Synaptic Transmission. Neuron 1997, 18, 483–491. [Google Scholar] [CrossRef] [Green Version]
- Talbot, J.D.; David, G.; Barrett, E.F. Inhibition of Mitochondrial Ca2+ Uptake Affects Phasic Release from Motor Terminals Differently Depending on External [Ca2+]. J. Neurophysiol. 2003, 90, 491–502. [Google Scholar] [CrossRef] [PubMed]
- Levy, M.; Faas, G.C.; Saggau, P.; Craigen, W.J.; Sweatt, J.D. Mitochondrial Regulation of Synaptic Plasticity in the Hippocampus. J. Biol Chem. 2003, 278, 17727–17734. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kang, J.-S.; Tian, J.-H.; Pan, P.-Y.; Zald, P.; Li, C.; Deng, C.; Sheng, Z.-H. Docking of Axonal Mitochondria by Syntaphilin Controls Their Mobility and Affects Short-Term Facilitation. Cell 2008, 132, 137–148. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- LaFerla, F.M. Calcium Dyshomeostasis and Intracellular Signalling in Alzheimer’s Disease. Nat. Rev. Neurosci. 2002, 3, 862–872. [Google Scholar] [CrossRef] [PubMed]
- Hara, M.R.; Snyder, S.H. Cell Signaling and Neuronal Death. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 117–141. [Google Scholar] [CrossRef]
- Kennedy, M.B.; Beale, H.C.; Carlisle, H.J.; Washburn, L.R. Integration of Biochemical Signalling in Spines. Nat. Rev. Neurosci. 2005, 6, 423–434. [Google Scholar] [CrossRef]
- Malenka, R.C.; Bear, M.F. LTP and LTD: An Embarrassment of Riches. Neuron 2004, 44, 5–21. [Google Scholar] [CrossRef] [Green Version]
- Goodman, Y.; Mattson, M.P. Secreted Forms of Beta-Amyloid Precursor Protein Protect Hippocampal Neurons against Amyloid Beta-Peptide-Induced Oxidative Injury. Exp. Neurol. 1994, 128, 1–12. [Google Scholar] [CrossRef]
- Mattson, M.P.; Cheng, B.; Davis, D.; Bryant, K.; Lieberburg, I.; Rydel, R.E. Beta-Amyloid Peptides Destabilize Calcium Homeostasis and Render Human Cortical Neurons Vulnerable to Excitotoxicity. J. Neurosci. 1992, 12, 376–389. [Google Scholar] [CrossRef] [Green Version]
- Mattson, M.P.; Tomaselli, K.J.; Rydel, R.E. Calcium-Destabilizing and Neurodegenerative Effects of Aggregated Beta-Amyloid Peptide Are Attenuated by Basic FGF. Brain Res. 1993, 621, 35–49. [Google Scholar] [CrossRef]
- Ferreira, S.T.; Klein, W.L. The Aβ Oligomer Hypothesis for Synapse Failure and Memory Loss in Alzheimer’s Disease. Neurobiol. Learn. Memb. 2011, 96, 529–543. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gan, K.J.; Silverman, M.A. Dendritic and Axonal Mechanisms of Ca2+ Elevation Impair BDNF Transport in Aβ Oligomer-Treated Hippocampal Neurons. Mol. Biol. Cell 2015, 26, 1058–1071. [Google Scholar] [CrossRef]
- Peng, T.I.; Greenamyre, J.T. Privileged Access to Mitochondria of Calcium Influx through N-Methyl-D-Aspartate Receptors. Mol. Pharm. 1998, 53, 974–980. [Google Scholar]
- Shoshan-Barmatz, V.; Nahon-Crystal, E.; Shteinfer-Kuzmine, A.; Gupta, R. VDAC1, Mitochondrial Dysfunction, and Alzheimer’s Disease. Pharmacol. Res. 2018, 131, 87–101. [Google Scholar] [CrossRef] [PubMed]
- Swerdlow, R.H. Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease. J. Alzheimer Dis. 2018, 62, 1403–1416. [Google Scholar] [CrossRef] [Green Version]
- Du, H.; Guo, L.; Fang, F.; Chen, D.; Sosunov, A.A.; McKhann, G.M.; Yan, Y.; Wang, C.; Zhang, H.; Molkentin, J.D.; et al. Cyclophilin D Deficiency Attenuates Mitochondrial and Neuronal Perturbation and Ameliorates Learning and Memory in Alzheimer’s Disease. Nat. Med. 2008, 14, 1097–1105. [Google Scholar] [CrossRef] [PubMed]
- Youle, R.J.; Narendra, D.P. Mechanisms of Mitophagy. Nat. Rev. Mol. Cell Biol. 2011, 12, 9–14. [Google Scholar] [CrossRef]
- Zhao, N.; Yan, Q.-W.; Xia, J.; Zhang, X.-L.; Li, B.-X.; Yin, L.-Y.; Xu, B. Treadmill Exercise Attenuates Aβ-Induced Mitochondrial Dysfunction and Enhances Mitophagy Activity in APP/PS1 Transgenic Mice. Neurochem. Res. 2020, 45, 1202–1214. [Google Scholar] [CrossRef]
- Fang, E.F.; Hou, Y.; Palikaras, K.; Adriaanse, B.A.; Kerr, J.S.; Yang, B.; Lautrup, S.; Hasan-Olive, M.M.; Caponio, D.; Dan, X.; et al. Mitophagy Inhibits Amyloid-β and Tau Pathology and Reverses Cognitive Deficits in Models of Alzheimer’s Disease. Nat. Neurosci. 2019, 22, 401–412. [Google Scholar] [CrossRef]
- Jadiya, P.; Kolmetzky, D.W.; Tomar, D.; Di Meco, A.; Lombardi, A.A.; Lambert, J.P.; Luongo, T.S.; Ludtmann, M.H.; Praticò, D.; Elrod, J.W. Impaired Mitochondrial Calcium Efflux Contributes to Disease Progression in Models of Alzheimer’s Disease. Nat. Commun. 2019, 10, 3885. [Google Scholar] [CrossRef]
- Rintoul, G.L.; Filiano, A.J.; Brocard, J.B.; Kress, G.J.; Reynolds, I.J. Glutamate Decreases Mitochondrial Size and Movement in Primary Forebrain Neurons. J. Neurosci. 2003, 23, 7881–7888. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chang, D.T.W.; Honick, A.S.; Reynolds, I.J. Mitochondrial Trafficking to Synapses in Cultured Primary Cortical Neurons. J. Neurosci. 2006, 26, 7035–7045. [Google Scholar] [CrossRef] [PubMed]
- Macaskill, A.F.; Rinholm, J.E.; Twelvetrees, A.E.; Arancibia-Carcamo, I.L.; Muir, J.; Fransson, A.; Aspenstrom, P.; Attwell, D.; Kittler, J.T. Miro1 Is a Calcium Sensor for Glutamate Receptor-Dependent Localization of Mitochondria at Synapses. Neuron 2009, 61, 541–555. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Schwarz, T.L. The Mechanism of Ca2+ -Dependent Regulation of Kinesin-Mediated Mitochondrial Motility. Cell 2009, 136, 163–174. [Google Scholar] [CrossRef] [Green Version]
- Han, X.-J.; Lu, Y.-F.; Li, S.-A.; Kaitsuka, T.; Sato, Y.; Tomizawa, K.; Nairn, A.C.; Takei, K.; Matsui, H.; Matsushita, M. CaM Kinase I Alpha-Induced Phosphorylation of Drp1 Regulates Mitochondrial Morphology. J. Cell Biol. 2008, 182, 573–585. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Duyckaerts, C.; Potier, M.-C.; Delatour, B. Alzheimer Disease Models and Human Neuropathology: Similarities and Differences. Acta Neuropathol. 2008, 115, 5–38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jacobsen, J.S.; Wu, C.-C.; Redwine, J.M.; Comery, T.A.; Arias, R.; Bowlby, M.; Martone, R.; Morrison, J.H.; Pangalos, M.N.; Reinhart, P.H.; et al. Early-Onset Behavioral and Synaptic Deficits in a Mouse Model of Alzheimer’s Disease. Proc. Natl. Acad. Sci. USA 2006, 103, 5161–5166. [Google Scholar] [CrossRef] [Green Version]
- Busche, M.A.; Chen, X.; Henning, H.A.; Reichwald, J.; Staufenbiel, M.; Sakmann, B.; Konnerth, A. Critical Role of Soluble Amyloid-β for Early Hippocampal Hyperactivity in a Mouse Model of Alzheimer’s Disease. Proc. Natl. Acad. Sci. USA 2012, 109, 8740–8745. [Google Scholar] [CrossRef] [Green Version]
- Zott, B.; Busche, M.A.; Sperling, R.A.; Konnerth, A. What Happens with the Circuit in Alzheimer’s Disease in Mice and Humans? Annu Rev. Neurosci. 2018, 41, 277–297. [Google Scholar] [CrossRef] [PubMed]
- Zott, B.; Simon, M.M.; Hong, W.; Unger, F.; Chen-Engerer, H.-J.; Frosch, M.P.; Sakmann, B.; Walsh, D.M.; Konnerth, A. A Vicious Cycle of β Amyloid–Dependent Neuronal Hyperactivation. Science 2019, 365, 559–565. [Google Scholar] [CrossRef] [PubMed]
- Harris, S.S.; Wolf, F.; De Strooper, B.; Busche, M.A. Tipping the Scales: Peptide-Dependent Dysregulation of Neural Circuit Dynamics in Alzheimer’s Disease. Neuron 2020, 107, 417–435. [Google Scholar] [CrossRef]
- D’Amelio, M.; Cavallucci, V.; Middei, S.; Marchetti, C.; Pacioni, S.; Ferri, A.; Diamantini, A.; De Zio, D.; Carrara, P.; Battistini, L.; et al. Caspase-3 Triggers Early Synaptic Dysfunction in a Mouse Model of Alzheimer’s Disease. Nat. Neurosci. 2011, 14, 69–76. [Google Scholar] [CrossRef] [Green Version]
- Nardi Cesarini, E.; Babiloni, C.; Salvadori, N.; Farotti, L.; Del Percio, C.; Pascarelli, M.T.; Noce, G.; Lizio, R.; Da Re, F.; Isella, V.; et al. Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics. Front. Neurol. 2020, 11. [Google Scholar] [CrossRef]
- Keret, O.; Hoang, T.D.; Xia, F.; Rosen, H.J.; Yaffe, K. Association of Late-Onset Unprovoked Seizures of Unknown Etiology With the Risk of Developing Dementia in Older Veterans. JAMA Neurol. 2020, 77, 710–715. [Google Scholar] [CrossRef] [PubMed]
- Meyer-Luehmann, M.; Coomaraswamy, J.; Bolmont, T.; Kaeser, S.; Schaefer, C.; Kilger, E.; Neuenschwander, A.; Abramowski, D.; Frey, P.; Jaton, A.L.; et al. Exogenous Induction of Cerebral Beta-Amyloidogenesis Is Governed by Agent and Host. Science 2006, 313, 1781–1784. [Google Scholar] [CrossRef]
- Eisele, Y.S.; Obermüller, U.; Heilbronner, G.; Baumann, F.; Kaeser, S.A.; Wolburg, H.; Walker, L.C.; Staufenbiel, M.; Heikenwalder, M.; Jucker, M. Peripherally Applied Abeta-Containing Inoculates Induce Cerebral Beta-Amyloidosis. Science 2010, 330, 980–982. [Google Scholar] [CrossRef] [Green Version]
- Liu, P.; Reed, M.N.; Kotilinek, L.A.; Grant, M.K.O.; Forster, C.L.; Qiang, W.; Shapiro, S.L.; Reichl, J.H.; Chiang, A.C.A.; Jankowsky, J.L.; et al. Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration. Cell Rep. 2015, 11, 1760–1771. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cline, E.N.; Bicca, M.A.; Viola, K.L.; Klein, W.L. The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade. J. Alzheimer Dis. 2018, 64, S567–S610. [Google Scholar] [CrossRef] [Green Version]
- Selkoe, D.J. Alzheimer’s Disease Is a Synaptic Failure. Science 2002, 298, 789–791. [Google Scholar] [CrossRef] [Green Version]
- Hsia, A.Y.; Masliah, E.; McConlogue, L.; Yu, G.Q.; Tatsuno, G.; Hu, K.; Kholodenko, D.; Malenka, R.C.; Nicoll, R.A.; Mucke, L. Plaque-Independent Disruption of Neural Circuits in Alzheimer’s Disease Mouse Models. Proc. Natl. Acad. Sci. USA 1999, 96, 3228–3233. [Google Scholar] [CrossRef] [Green Version]
- Kamenetz, F.; Tomita, T.; Hsieh, H.; Seabrook, G.; Borchelt, D.; Iwatsubo, T.; Sisodia, S.; Malinow, R. APP Processing and Synaptic Function. Neuron 2003, 37, 925–937. [Google Scholar] [CrossRef] [Green Version]
- Cirrito, J.R.; Yamada, K.A.; Finn, M.B.; Sloviter, R.S.; Bales, K.R.; May, P.C.; Schoepp, D.D.; Paul, S.M.; Mennerick, S.; Holtzman, D.M. Synaptic Activity Regulates Interstitial Fluid Amyloid-Beta Levels in Vivo. Neuron 2005, 48, 913–922. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wei, W.; Nguyen, L.N.; Kessels, H.W.; Hagiwara, H.; Sisodia, S.; Malinow, R. Amyloid Beta from Axons and Dendrites Reduces Local Spine Number and Plasticity. Nat. Neurosci. 2010, 13, 190–196. [Google Scholar] [CrossRef] [PubMed]
- Puzzo, D.; Privitera, L.; Leznik, E.; Fa, M.; Staniszewski, A.; Palmeri, A.; Arancio, O. Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus. J. Neurosci. 2008, 28, 14537–14545. [Google Scholar] [CrossRef]
- Abramov, E.; Dolev, I.; Fogel, H.; Ciccotosto, G.D.; Ruff, E.; Slutsky, I. Amyloid-β as a Positive Endogenous Regulator of Release Probability at Hippocampal Synapses. Nat. Neurosci. 2009, 12, 1567–1576. [Google Scholar] [CrossRef]
- Shankar, G.M.; Bloodgood, B.L.; Townsend, M.; Walsh, D.M.; Selkoe, D.J.; Sabatini, B.L. Natural Oligomers of the Alzheimer Amyloid- Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway. J. Neurosci. 2007, 27, 2866–2875. [Google Scholar] [CrossRef]
- Dineley, K.T.; Bell, K.A.; Bui, D.; Sweatt, J.D. Beta -Amyloid Peptide Activates Alpha 7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes. J. Biol. Chem. 2002, 277, 25056–25061. [Google Scholar] [CrossRef] [Green Version]
- Traynelis, S.F.; Wollmuth, L.P.; McBain, C.J.; Menniti, F.S.; Vance, K.M.; Ogden, K.K.; Hansen, K.B.; Yuan, H.; Myers, S.J.; Dingledine, R. Glutamate Receptor Ion Channels: Structure, Regulation, and Function. Pharm. Rev. 2010, 62, 405–496. [Google Scholar] [CrossRef] [Green Version]
- Kullmann, D.M.; Lamsa, K.P. Long-Term Synaptic Plasticity in Hippocampal Interneurons. Nat. Rev. Neurosci. 2007, 8, 687–699. [Google Scholar] [CrossRef]
- Hsieh, H.; Boehm, J.; Sato, C.; Iwatsubo, T.; Tomita, T.; Sisodia, S.; Malinow, R. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss. Neuron 2006, 52, 831–843. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, L. Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity. Science 2004, 304, 1021–1024. [Google Scholar] [CrossRef] [Green Version]
- Wang, Q.; Walsh, D.M.; Rowan, M.J.; Selkoe, D.J.; Anwyl, R. Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid Beta-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and P38 Mitogen-Activated Protein Kinase as Well as Metabotropic Glutamate Receptor Type 5. J. Neurosci. 2004, 24, 3370–3378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lau, C.G.; Zukin, R.S. NMDA Receptor Trafficking in Synaptic Plasticity and Neuropsychiatric Disorders. Nat. Rev. Neurosci. 2007, 8, 413–426. [Google Scholar] [CrossRef] [PubMed]
- Barria, A.; Malinow, R. NMDA Receptor Subunit Composition Controls Synaptic Plasticity by Regulating Binding to CaMKII. Neuron 2005, 48, 289–301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Turrigiano, G.G.; Nelson, S.B. Hebb and Homeostasis in Neuronal Plasticity. Curr. Opin. Neurobiol. 2000, 10, 358–364. [Google Scholar] [CrossRef]
- Davis, G.W. Homeostatic Control of Neural Activity: From Phenomenology to Molecular Design. Annu Rev. Neurosci. 2006, 29, 307–323. [Google Scholar] [CrossRef] [Green Version]
- Turrigiano, G.G. The Dialectic of Hebb and Homeostasis. Philos. Trans. R. Soc. B Biol. Sci. 2017, 372, 20160258. [Google Scholar] [CrossRef] [Green Version]
- Turrigiano, G.G. The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses. Cell 2008, 135, 422–435. [Google Scholar] [CrossRef] [Green Version]
- Pozo, K.; Goda, Y. Unraveling Mechanisms of Homeostatic Synaptic Plasticity. Neuron 2010, 66, 337–351. [Google Scholar] [CrossRef] [Green Version]
- Abraham, W.C. Metaplasticity: Tuning Synapses and Networks for Plasticity. Nat. Rev. Neurosci. 2008, 9, 387. [Google Scholar] [CrossRef] [PubMed]
- Lalonde, R.; Fukuchi, K.-I.; Strazielle, C. Neurologic and Motor Dysfunctions in APP Transgenic Mice. Rev. Neurosci. 2012, 23, 363–379. [Google Scholar] [CrossRef] [Green Version]
- Vogt, D.L.; Thomas, D.; Galvan, V.; Bredesen, D.E.; Lamb, B.T.; Pimplikar, S.W. Abnormal Neuronal Networks and Seizure Susceptibility in Mice Overexpressing the APP Intracellular Domain. Neurobiol. Aging 2011, 32, 1725–1729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cirrito, J.R.; Kang, J.-E.; Lee, J.; Stewart, F.R.; Verges, D.K.; Silverio, L.M.; Bu, G.; Mennerick, S.; Holtzman, D.M. Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-Beta in Vivo. Neuron 2008, 58, 42–51. [Google Scholar] [CrossRef] [Green Version]
- Kauer, J.A.; Malenka, R.C. Synaptic Plasticity and Addiction. Nat. Rev. Neurosci. 2007, 8, 844–858. [Google Scholar] [CrossRef] [PubMed]
- Bukke, V.N.; Archana, M.; Villani, R.; Romano, A.D.; Wawrzyniak, A.; Balawender, K.; Orkisz, S.; Beggiato, S.; Serviddio, G.; Cassano, T. The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy. Int. J. Mol. Sci. 2020, 21, 7452. [Google Scholar] [CrossRef] [PubMed]
- Reinders, N.R.; Pao, Y.; Renner, M.C.; da Silva-Matos, C.M.; Lodder, T.R.; Malinow, R.; Kessels, H.W. Amyloid-β Effects on Synapses and Memory Require AMPA Receptor Subunit GluA3. Proc. Natl. Acad. Sci. USA 2016, 113, E6526–E6534. [Google Scholar] [CrossRef] [Green Version]
- Guntupalli, S.; Jang, S.E.; Zhu, T.; Huganir, R.L.; Widagdo, J.; Anggono, V. GluA1 Subunit Ubiquitination Mediates Amyloid-β-Induced Loss of Surface α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Receptors. J. Biol. Chem. 2017, 292, 8186–8194. [Google Scholar] [CrossRef] [Green Version]
- Zhao, D.; Watson, J.B.; Xie, C.-W. Amyloid Beta Prevents Activation of Calcium/Calmodulin-Dependent Protein Kinase II and AMPA Receptor Phosphorylation during Hippocampal Long-Term Potentiation. J. Neurophysiol. 2004, 92, 2853–2858. [Google Scholar] [CrossRef]
- Lee, H.-K.; Takamiya, K.; Han, J.-S.; Man, H.; Kim, C.-H.; Rumbaugh, G.; Yu, S.; Ding, L.; He, C.; Petralia, R.S.; et al. Phosphorylation of the AMPA Receptor GluR1 Subunit Is Required for Synaptic Plasticity and Retention of Spatial Memory. Cell 2003, 112, 631–643. [Google Scholar] [CrossRef] [Green Version]
- Lee, H.K.; Barbarosie, M.; Kameyama, K.; Bear, M.F.; Huganir, R.L. Regulation of Distinct AMPA Receptor Phosphorylation Sites during Bidirectional Synaptic Plasticity. Nature 2000, 405, 955–959. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.-K.; Takamiya, K.; He, K.; Song, L.; Huganir, R.L. Specific Roles of AMPA Receptor Subunit GluR1 (GluA1) Phosphorylation Sites in Regulating Synaptic Plasticity in the CA1 Region of Hippocampus. J. Neurophysiol. 2010, 103, 479–489. [Google Scholar] [CrossRef] [Green Version]
- Kim, S.; Ziff, E.B. Calcineurin Mediates Synaptic Scaling via Synaptic Trafficking of Ca2+-Permeable AMPA Receptors. PLoS Biol. 2014, 12, e1001900. [Google Scholar] [CrossRef] [PubMed]
- Goel, A.; Xu, L.W.; Snyder, K.P.; Song, L.; Goenaga-Vazquez, Y.; Megill, A.; Takamiya, K.; Huganir, R.L.; Lee, H.-K. Phosphorylation of AMPA Receptors Is Required for Sensory Deprivation-Induced Homeostatic Synaptic Plasticity. PLoS ONE 2011, 6, e18264. [Google Scholar] [CrossRef]
- Desai, N.S.; Cudmore, R.H.; Nelson, S.B.; Turrigiano, G.G. Critical Periods for Experience-Dependent Synaptic Scaling in Visual Cortex. Nat. Neurosci. 2002, 5, 783–789. [Google Scholar] [CrossRef] [PubMed]
- Keck, T.; Keller, G.B.; Jacobsen, R.I.; Eysel, U.T.; Bonhoeffer, T.; Hübener, M. Synaptic Scaling and Homeostatic Plasticity in the Mouse Visual Cortex in Vivo. Neuron 2013, 80, 327–334. [Google Scholar] [CrossRef] [Green Version]
- He, K.; Song, L.; Cummings, L.W.; Goldman, J.; Huganir, R.L.; Lee, H.-K. Stabilization of Ca2+-Permeable AMPA Receptors at Perisynaptic Sites by GluR1-S845 Phosphorylation. Proc. Natl. Acad. Sci. USA 2009, 106, 20033–20038. [Google Scholar] [CrossRef] [Green Version]
- Garcia-Bereguiain, M.A.; Gonzalez-Islas, C.; Lindsly, C.; Butler, E.; Hill, A.W.; Wenner, P. In Vivo Synaptic Scaling Is Mediated by GluA2-Lacking AMPA Receptors in the Embryonic Spinal Cord. J. Neurosci. 2013, 33, 6791–6799. [Google Scholar] [CrossRef] [Green Version]
- Gonzalez-Islas, C.; Wenner, P. Spontaneous Network Activity in the Embryonic Spinal Cord Regulates AMPAergic and GABAergic Synaptic Strength. Neuron 2006, 49, 563–575. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cuevas, M.E.; Haensgen, H.; Sepúlveda, F.J.; Zegers, G.; Roa, J.; Opazo, C.; Aguayo, L.G. Soluble Aβ(1-40) Peptide Increases Excitatory Neurotransmission and Induces Epileptiform Activity in Hippocampal Neurons. J. Alzheimer Dis. 2011, 23, 673–687. [Google Scholar] [CrossRef] [Green Version]
- Lei, M.; Xu, H.; Li, Z.; Wang, Z.; O’Malley, T.T.; Zhang, D.; Walsh, D.M.; Xu, P.; Selkoe, D.J.; Li, S. Soluble Aβ Oligomers Impair Hippocampal LTP by Disrupting Glutamatergic/GABAergic Balance. Neurobiol. Dis. 2016, 85, 111–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alcantara-Gonzalez, D.; Villasana-Salazar, B.; Peña-Ortega, F. Single Amyloid-Beta Injection Exacerbates 4-Aminopyridine-Induced Seizures and Changes Synaptic Coupling in the Hippocampus. Hippocampus 2019, 29, 1150–1164. [Google Scholar] [CrossRef] [PubMed]
- Costa, C. Alzheimer’s Disease and Late-Onset Epilepsy of Unknown Origin: Two Faces of Beta Amyloid Pathology. Neurobiol. Aging 2019, 7. [Google Scholar] [CrossRef] [PubMed]
- Westmark, C.J.; Westmark, P.R.; Beard, A.M.; Hildebrandt, S.M.; Malter, J.S. Seizure Susceptibility and Mortality in Mice That Over-Express Amyloid Precursor Protein. Int. J. Clin. Exp. Pathol. 2008, 1, 157–168. [Google Scholar] [PubMed]
- Müller-Schiffmann, A.; Herring, A.; Abdel-Hafiz, L.; Chepkova, A.N.; Schäble, S.; Wedel, D.; Horn, A.H.C.; Sticht, H.; de Souza Silva, M.A.; Gottmann, K.; et al. Amyloid-β Dimers in the Absence of Plaque Pathology Impair Learning and Synaptic Plasticity. Brain 2016, 139, 509–525. [Google Scholar] [CrossRef] [Green Version]
- Smith, L.M.; Strittmatter, S.M. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity. Cold Spring Harb. Perspect. Med. 2017, 7. [Google Scholar] [CrossRef] [Green Version]
- Ziyatdinova, S.; Rönnbäck, A.; Gurevicius, K.; Miszczuk, D.; Graff, C.; Winblad, B.; Pitkänen, A.; Tanila, H. Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer’s Disease. Curr. Alzheimer Res. 2016, 13, 817–830. [Google Scholar] [CrossRef]
- Busche, M.A.; Eichhoff, G.; Adelsberger, H.; Abramowski, D.; Wiederhold, K.-H.; Haass, C.; Staufenbiel, M.; Konnerth, A.; Garaschuk, O. Clusters of Hyperactive Neurons near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease. Science 2008, 321, 1686–1689. [Google Scholar] [CrossRef] [Green Version]
- Vezzani, A.; Granata, T. Brain Inflammation in Epilepsy: Experimental and Clinical Evidence. Epilepsia 2005, 46, 1724–1743. [Google Scholar] [CrossRef] [PubMed]
- Dejakaisaya, H.; Kwan, P.; Jones, N.C. Astrocyte and Glutamate Involvement in the Pathogenesis of Epilepsy in Alzheimer’s Disease. Epilepsia 2021. [Google Scholar] [CrossRef]
- Ren, S.-Q.; Yao, W.; Yan, J.-Z.; Jin, C.; Yin, J.-J.; Yuan, J.; Yu, S.; Cheng, Z. Amyloid β Causes Excitation/Inhibition Imbalance through Dopamine Receptor 1-Dependent Disruption of Fast-Spiking GABAergic Input in Anterior Cingulate Cortex. Sci. Rep. 2018, 8, 302. [Google Scholar] [CrossRef]
- Kurup, P.; Zhang, Y.; Xu, J.; Venkitaramani, D.V.; Haroutunian, V.; Greengard, P.; Nairn, A.C.; Lombroso, P.J. Abeta-Mediated NMDA Receptor Endocytosis in Alzheimer’s Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP61. J. Neurosci. 2010, 30, 5948–5957. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ferreira, I.L.; Ferreiro, E.; Schmidt, J.; Cardoso, J.M.; Pereira, C.M.F.; Carvalho, A.L.; Oliveira, C.R.; Rego, A.C. Aβ and NMDAR Activation Cause Mitochondrial Dysfunction Involving ER Calcium Release. Neurobiol. Aging 2015, 36, 680–692. [Google Scholar] [CrossRef] [Green Version]
- Rissman, R.A.; De Blas, A.L.; Armstrong, D.M. GABA(A) Receptors in Aging and Alzheimer’s Disease. J. Neurochem. 2007, 103, 1285–1292. [Google Scholar] [CrossRef] [PubMed]
- Farrant, M.; Nusser, Z. Variations on an Inhibitory Theme: Phasic and Tonic Activation of GABA(A) Receptors. Nat. Rev. Neurosci. 2005, 6, 215–229. [Google Scholar] [CrossRef] [PubMed]
- Ulrich, D. Amyloid-β Impairs Synaptic Inhibition via GABA(A) Receptor Endocytosis. J. Neurosci. 2015, 35, 9205–9210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhan, X.-Q.; Yao, J.-J.; Liu, D.-D.; Ma, Q.; Mei, Y.-A. Aβ40 Modulates GABA(A) Receptor A6 Subunit Expression and Rat Cerebellar Granule Neuron Maturation through the ERK/MTOR Pathway. J. Neurochem. 2014, 128, 350–362. [Google Scholar] [CrossRef]
- Li, S.; Selkoe, D.J. A Mechanistic Hypothesis for the Impairment of Synaptic Plasticity by Soluble Aβ Oligomers from Alzheimer’s Brain. J. Neurochem. 2020, 154, 583–597. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Jackson, R.J.; Hong, W.; Taylor, W.M.; Corbett, G.T.; Moreno, A.; Liu, W.; Li, S.; Frosch, M.P.; Slutsky, I.; et al. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP. J. Neurosci. 2017, 37, 11947–11966. [Google Scholar] [CrossRef] [Green Version]
- Palop, J.J.; Mucke, L. Network Abnormalities and Interneuron Dysfunction in Alzheimer Disease. Nat. Rev. Neurosci. 2016, 17, 777–792. [Google Scholar] [CrossRef]
- Wang, B.; Wang, Z.; Sun, L.; Yang, L.; Li, H.; Cole, A.L.; Rodriguez-Rivera, J.; Lu, H.-C.; Zheng, H. The Amyloid Precursor Protein Controls Adult Hippocampal Neurogenesis through GABAergic Interneurons. J. Neurosci. 2014, 34, 13314–13325. [Google Scholar] [CrossRef] [Green Version]
- Dickerson, B.C.; Salat, D.H.; Greve, D.N.; Chua, E.F.; Rand-Giovannetti, E.; Rentz, D.M.; Bertram, L.; Mullin, K.; Tanzi, R.E.; Blacker, D.; et al. Increased Hippocampal Activation in Mild Cognitive Impairment Compared to Normal Aging and AD. Neurology 2005, 65, 404–411. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bakker, A.; Krauss, G.L.; Albert, M.S.; Speck, C.L.; Jones, L.R.; Stark, C.E.; Yassa, M.A.; Bassett, S.S.; Shelton, A.L.; Gallagher, M. Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment. Neuron 2012, 74, 467–474. [Google Scholar] [CrossRef] [Green Version]
- Bakker, A.; Albert, M.S.; Krauss, G.; Speck, C.L.; Gallagher, M. Response of the Medial Temporal Lobe Network in Amnestic Mild Cognitive Impairment to Therapeutic Intervention Assessed by FMRI and Memory Task Performance. Neuroimage Clin. 2015, 7, 688–698. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vossel, K.A.; Tartaglia, M.C.; Nygaard, H.B.; Zeman, A.Z.; Miller, B.L. Epileptic Activity in Alzheimer’s Disease: Causes and Clinical Relevance. Lancet Neurol. 2017, 16, 311–322. [Google Scholar] [CrossRef] [Green Version]
- Lam, A.D.; Deck, G.; Goldman, A.; Eskandar, E.N.; Noebels, J.; Cole, A.J. Silent Hippocampal Seizures and Spikes Identified by Foramen Ovale Electrodes in Alzheimer’s Disease. Nat. Med. 2017, 23, 678–680. [Google Scholar] [CrossRef] [PubMed]
- Vossel, K.A.; Beagle, A.J.; Rabinovici, G.D.; Shu, H.; Lee, S.E.; Naasan, G.; Hegde, M.; Cornes, S.B.; Henry, M.L.; Nelson, A.B.; et al. Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease. JAMA Neurol. 2013, 70, 1158–1166. [Google Scholar] [CrossRef]
- Joutsa, J.; Rinne, J.O.; Hermann, B.; Karrasch, M.; Anttinen, A.; Shinnar, S.; Sillanpää, M. Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later. JAMA Neurol. 2017, 74, 583–590. [Google Scholar] [CrossRef]
- Paula-Lima, A.C.; Brito-Moreira, J.; Ferreira, S.T. Deregulation of Excitatory Neurotransmission Underlying Synapse Failure in Alzheimer’s Disease. J. Neurochem. 2013, 126, 191–202. [Google Scholar] [CrossRef] [PubMed]
- Tozzi, A.; Sclip, A.; Tantucci, M.; de Iure, A.; Ghiglieri, V.; Costa, C.; Di Filippo, M.; Borsello, T.; Calabresi, P. Region- and Age-Dependent Reductions of Hippocampal Long-Term Potentiation and NMDA to AMPA Ratio in a Genetic Model of Alzheimer’s Disease. Neurobiol. Aging 2015, 36, 123–133. [Google Scholar] [CrossRef] [PubMed]
- Lipton, S.A. Paradigm Shift in Neuroprotection by NMDA Receptor Blockade: Memantine and Beyond. Nat. Rev. Drug Discov. 2006, 5, 160–170. [Google Scholar] [CrossRef] [PubMed]
- Schmitt, H.P. On the Paradox of Ion Channel Blockade and Its Benefits in the Treatment of Alzheimer Disease. Med. Hypotheses 2005, 65, 259–265. [Google Scholar] [CrossRef]
- Abbas, G.; Mahmood, W.; Kabir, N. Recent Progress on the Role of GABAergic Neurotransmission in the Pathogenesis of Alzheimer’s Disease. Rev. Neurosci. 2016, 27, 449–455. [Google Scholar] [CrossRef]
- Lu, M.-H.; Zhao, X.-Y.; Xu, D.-E.; Chen, J.-B.; Ji, W.-L.; Huang, Z.-P.; Pan, T.-T.; Xue, L.-L.; Wang, F.; Li, Q.-F.; et al. Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer’s Disease Model Mice. J. Alzheimer Dis. 2020, 75, 245–260. [Google Scholar] [CrossRef]
- Hijazi, S.; Heistek, T.S.; Scheltens, P.; Neumann, U.; Shimshek, D.R.; Mansvelder, H.D.; Smit, A.B.; van Kesteren, R.E. Early Restoration of Parvalbumin Interneuron Activity Prevents Memory Loss and Network Hyperexcitability in a Mouse Model of Alzheimer’s Disease. Mol. Psychiatry 2020, 25, 3380–3398. [Google Scholar] [CrossRef]
Type of Aβ | Interactions | Effects | Models | Ref. |
---|---|---|---|---|
Aβ1-40 oligomers | membranes | ↑ Ca2+ | GnRH neuronal cell line | [42] |
cultured endothelial cells | [43] | |||
bilayer membranes | [44,45] | |||
↓ neurotransmitter release | hippocampal neurons | [46] | ||
FzR | ↓ Wnt/Fz signaling | N2A cells and L-cells | [47] | |
mitochondria | ↓ complex IV activity | APP Tg mice and human brain samples | [48] | |
Aβ1-42 oligomers | membranes | ↑ Ca2+ | lipid vesicles | [49] |
cultured endothelial cells | [43] | |||
SH-SY5Y cells, oocytes | [50,51] | |||
hippocampal neurons | [52] | |||
↓ axonal transport | ||||
↑ non-specific ionic flux | neuronal HEK293 membranes | [53] | ||
↓ mitochondrial membrane potential | hippocampal neurons | [54] | ||
↑ oxidative stress | ||||
IR | ↓ activity of IR | hippocampal and cortical neurons | [55] | |
mGluR/NMDAR | ↑ Ca2+ | hippocampal neurons | [56] | |
↑ synaptic glutamate, LTD | [57] | |||
mGluR | ↑ synaptic damage | [56] | ||
mitochondria | ↓ mitochondrial membrane potential | APP Tg mice and human brain samples | [48] | |
↑ oxidative stress | ||||
NMDAR | hippocampal neurons | [58] | ||
p75NTR | ↑ NGF-mediated cell death | PC12 cells | [59] | |
α7/α4β2nAChRs | ↑ Ca2+ | hippocampal neurons | [60] | |
cortical neurons | [61] | |||
↓ surface AMPAR expression | hippocampal neurons | [60] | ||
↑ endocytosis of NMDAR | cortical neurons | [61] | ||
D1 DAR | ↑ epileptic-like activity | APP Tg mice | [62] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sciaccaluga, M.; Megaro, A.; Bellomo, G.; Ruffolo, G.; Romoli, M.; Palma, E.; Costa, C. An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity? Int. J. Mol. Sci. 2021, 22, 5991. https://doi.org/10.3390/ijms22115991
Sciaccaluga M, Megaro A, Bellomo G, Ruffolo G, Romoli M, Palma E, Costa C. An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity? International Journal of Molecular Sciences. 2021; 22(11):5991. https://doi.org/10.3390/ijms22115991
Chicago/Turabian StyleSciaccaluga, Miriam, Alfredo Megaro, Giovanni Bellomo, Gabriele Ruffolo, Michele Romoli, Eleonora Palma, and Cinzia Costa. 2021. "An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?" International Journal of Molecular Sciences 22, no. 11: 5991. https://doi.org/10.3390/ijms22115991